ATE72991T1 - Nasale verabreichung von arzneimitteln. - Google Patents

Nasale verabreichung von arzneimitteln.

Info

Publication number
ATE72991T1
ATE72991T1 AT87104766T AT87104766T ATE72991T1 AT E72991 T1 ATE72991 T1 AT E72991T1 AT 87104766 T AT87104766 T AT 87104766T AT 87104766 T AT87104766 T AT 87104766T AT E72991 T1 ATE72991 T1 AT E72991T1
Authority
AT
Austria
Prior art keywords
medications
nasal administration
nasal
administration
drugs
Prior art date
Application number
AT87104766T
Other languages
English (en)
Inventor
Edwin I Stoltz
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Corp filed Critical Fisons Corp
Application granted granted Critical
Publication of ATE72991T1 publication Critical patent/ATE72991T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Instructional Devices (AREA)
AT87104766T 1986-04-23 1987-03-31 Nasale verabreichung von arzneimitteln. ATE72991T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85511486A 1986-04-23 1986-04-23
EP87104766A EP0242643B1 (de) 1986-04-23 1987-03-31 Nasale Verabreichung von Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE72991T1 true ATE72991T1 (de) 1992-03-15

Family

ID=25320391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87104766T ATE72991T1 (de) 1986-04-23 1987-03-31 Nasale verabreichung von arzneimitteln.

Country Status (11)

Country Link
US (1) US5902789A (de)
EP (1) EP0242643B1 (de)
JP (1) JPH0825906B2 (de)
AT (1) ATE72991T1 (de)
AU (1) AU7076887A (de)
CA (1) CA1291036C (de)
DE (1) DE3776946D1 (de)
DK (1) DK203787A (de)
ES (1) ES2032770T3 (de)
FI (1) FI871750L (de)
IE (1) IE59764B1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
KR900701310A (ko) * 1988-11-14 1990-12-01 오스카 아끼히꼬 인터페론 경비투여용 제제
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
DE4318398A1 (de) * 1993-06-03 1994-12-08 Merck Patent Gmbh Dexamethasonphosphat zur Infusionstherapie
ES2095183B1 (es) * 1994-06-29 1997-12-16 S A L V A T Lab Sa Composiciones acusosas gelificantes para la administracion intranasal de farmacos.
US6248789B1 (en) 1996-08-29 2001-06-19 Stuart L. Weg Administration of ketamine to manage pain and to reduce drug dependency
DE19826628C1 (de) * 1998-06-17 2000-07-20 Werner Kern Intranasale Verwendung von Insulin bei Hirnleistungsstörungen
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
MXPA01007895A (es) 1999-02-03 2003-07-21 Biosante Pharmaceuticals Inc Particulas terapeuticas de fosfato de calcio, metodos de manufactura y usos.
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
EP1187639A1 (de) 1999-06-04 2002-03-20 Delrx Pharmaceutical Corporation Formulierungen enthaltend dehydrierte Partikel pharmazeutischer Agenzien und ihr Herstellungsverfahren
CZ20021044A3 (cs) * 1999-09-24 2002-08-14 Smithkline Beecham Biologicals S. A. Pouľití antigenu chřipkového viru pro výrobu vakciny
IL148672A0 (en) * 1999-09-24 2002-09-12 Smithkline Beecham Biolog Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
US6894026B1 (en) * 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
JP2004535432A (ja) * 2001-06-22 2004-11-25 ベントレー ファーマシューティカルズ インコーポレイテッド 医薬組成物
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
JP2006505583A (ja) 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2515368A1 (en) * 2003-02-13 2004-08-26 Luciano Rossetti Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8211448B2 (en) 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
ATE378038T1 (de) * 2003-07-07 2007-11-15 Nares Ab Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
JP2007513199A (ja) * 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法
MXPA06009222A (es) * 2004-02-13 2007-03-08 Nod Pharmaceuticals Inc Particulas terapeuticas de fosfato de calcio y metodos para elaborar y utilizar los mismos.
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
US20090041812A1 (en) * 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use
WO2006088875A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels
EP1893396A2 (de) * 2005-05-09 2008-03-05 Foamix Ltd. Schäumbarer trägerstoff und pharmazeutsche zusammensetzungen daraus
KR20080064171A (ko) * 2005-10-20 2008-07-08 나스텍 파마수티컬 컴퍼니 인코포레이티드 속효성 인슐린의 비강내 투여
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8551454B2 (en) 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2254061A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Lh-releasing hormon zur nasalen applikation
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1554157A (en) * 1975-06-13 1979-10-17 Takeda Chemical Industries Ltd Stable insulin preparation for intra nasal administration
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4262021A (en) * 1977-08-18 1981-04-14 Pfizer Inc. Antiviral amine and amidine derivatives of glycerol and propanediols
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols
US4291060A (en) * 1978-08-15 1981-09-22 Pfizer Inc. Compounds derived from formylphenoxyacetic acid as antiviral agents in animals
US4543248A (en) * 1979-03-19 1985-09-24 The Upjohn Company Method for immunoregulation with 6-aryl pyrimidine compounds
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
US4424210A (en) * 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4423040A (en) * 1980-04-04 1983-12-27 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclohexan-2-ones
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
US4308272A (en) * 1980-10-03 1981-12-29 The Upjohn Company Process for treating hypertension
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
US4548814A (en) * 1980-12-18 1985-10-22 The Board Of Trustees Of The University Of Illinois Composition of matter and process
JPS58501125A (ja) * 1981-07-17 1983-07-14 ノルデイスク・インスリンラボラトリウム 安定な水性治療性インシユリン製剤及びその製造方法
US4414205A (en) * 1981-08-28 1983-11-08 University Patents, Inc. Cell growth inhibitory substances
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
US4593096A (en) * 1982-06-09 1986-06-03 The Upjohn Company Novel compounds and process for treating hypertension
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
CA1274774A (en) * 1985-04-15 1990-10-02 Kenneth S. Su Method for administering insulin

Also Published As

Publication number Publication date
JPS62281813A (ja) 1987-12-07
DE3776946D1 (de) 1992-04-09
JPH0825906B2 (ja) 1996-03-13
FI871750A7 (fi) 1987-10-24
DK203787D0 (da) 1987-04-22
ES2032770T3 (es) 1993-03-01
CA1291036C (en) 1991-10-22
EP0242643B1 (de) 1992-03-04
EP0242643A2 (de) 1987-10-28
DK203787A (da) 1987-10-24
EP0242643A3 (en) 1988-04-06
FI871750A0 (fi) 1987-04-22
IE870993L (en) 1987-10-23
IE59764B1 (en) 1994-03-23
FI871750L (fi) 1987-10-24
US5902789A (en) 1999-05-11
AU7076887A (en) 1987-10-29

Similar Documents

Publication Publication Date Title
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
IT1199760B (it) Dispositivo terapeutico per la somministrazione di medicamenti
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
DE3650101D1 (de) Analoga von Insulin und deren Herstellungsmethode.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
FI860111A7 (fi) Terapeutiska medel.
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
DE3585722D1 (de) Geraet zur iontophoretischen verabreichung von medikamenten.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DK527487D0 (da) Farmaceutiske praeparater med forlaenget afgivelse
DK99987A (da) Oestrogenpraeparater
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
FI863159A7 (fi) Sydänlääkkeinä käytettäviä heterosyklokarbonyyli- ja asetyylitiatsoloneja.
DE68921180D1 (de) Apparat für die Verabreichung von Medikamenten für die Veterinärmedizin.
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
DK269986A (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
FR2583755B1 (fr) Derives de 10 a-methoxy-6-methyl-ergoline, leur preparation et leur application en tant que medicament
KR870014091U (ko) 수간 약물 주입병
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT8421131A0 (it) Dispositivo e procedimento per somministrare medicinali.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time